Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Covidien introduces new alarm management system
According to Covidien, the alarm management system enhances the information provided by traditional pulse oximeters and supports efficient, comprehensive care of patients who are at risk for upper
According to Covidien, the alarm management system enhances the information provided by traditional pulse oximeters and supports efficient, comprehensive care of patients who are at risk for upper
Mr Doughty and Mr Kraus will assume responsibilities previously performed by John Borrell, who has left the company to pursue other opportunities. Additionally, the company announced that Nabil
According to ATS Medical, the ATS AP360 heart valve maximizes hemodynamic performance with a new supra-annular cuff design that facilitates implantation. The original ATS Medical Open Pivot heart
US-based Baxter International has reported a net income of $518m, or $0.83 per diluted share, for the first quarter of 2009, an increase of 20%, compared to $432m,
US-based GlobeImmune has initiated a Phase I clinical trial to investigate the safety and tolerability of a new Tarmogen, GI-6207, in patients with metastatic cancers that over-express carcinoembryonic
The FDA has given clearance to the ezlase for the following indications: for a temporary relief of minor muscle and joint pain and stiffness, minor arthritis pain, or
GlaxoSmithKline and Pfizer have entered into an agreement to create a new HIV company focused solely on research, development and commercialization of HIV medicines. GlaxoSmithKline (GSK) will initially
Somanetics, a developer of non-invasive patient monitoring systems, has received a new 510(k) clearance from the FDA to expand the labeling for its Invos cerebral/somatic oximeter. The new
Applied DNA Sciences, a provider of DNA security solutions, has opened an authentication laboratory in Huddersfield, Yorkshire, UK. The laboratory will produce forensic evidence of originality and product
Achillion Pharmaceuticals, a US-based biopharmaceutical company has announced that the US Patent & Trademark Office has granted Achillion a US patent related to the company’s NS4A antagonists to